Mylan (MYL +1%) gains on an upgrade to Buy from at Goldman, citing improved earnings visibility...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL +1%) gains on an upgrade to Buy from at Goldman, citing improved earnings visibility and an underestimated margin expansion led by the company's EpiPen product mix shift.